Home › Blood Disorders › New Jersey › Clifton
Blood Disorders clinical trials in Clifton, NJ
3 studies for Blood Disorders are looking for participants at sites in and around Clifton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
RecruitingPhase 2/3
- John Theurer Cancer Center / Hackensack University, Hackensack · 7 mi away
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RecruitingPhase 1
- John Theurer Cancer Center, Hackensack University Medical Center, Hackensack · 7 mi away
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
RecruitingPhase 2
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7 mi away
About Blood Disorders
Blood disorders affect one or more parts of the blood and prevent your blood from doing its job. Find out about the types, causes, and treatments.
More about Blood Disorders on MedlinePlus
Blood Disorders trials in other cities
- Houston, TX11 studies
- Atlanta, GA11 studies
- Boston, MA10 studies
- Los Angeles, CA10 studies
- New York City, NY9 studies
- The Bronx, NY8 studies
- Durham, NC7 studies
- Nashville, TN7 studies
- Mountain View, CA7 studies
- San Diego, CA6 studies
- Seattle, WA6 studies
- Indianapolis, IN5 studies
Other studies in Clifton
- Non-Small Cell Lung Cancer23 studies
- Multiple Myeloma15 studies
- Cancer (all types)13 studies
- Prostate Cancer12 studies
- Acute Myeloid Leukemia11 studies
- Ovarian Cancer11 studies
- Metastatic Cancer11 studies
- Breast Cancer11 studies
- Colorectal Cancer9 studies
- Lung Cancer9 studies
- Heart Failure9 studies
- Leukemia8 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.